Global Eye Drug Market Insights and Forecast to 2031

Report ID: 1156582 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
1 Study Coverage
    1.1 Eye Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Eye Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Drops
        1.2.3 Tablet & Capsule
    1.3 Market by Application
        1.3.1 Global Eye Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Glaucoma
        1.3.3 Retinal Disease
        1.3.4 Bacterial?Infection
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Eye Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Eye Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Eye Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Eye Drug Sales by Region
        2.4.1 Global Eye Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Eye Drug by Region (2023-2028)
    2.5 Global Eye Drug Revenue by Region
        2.5.1 Global Eye Drug Revenue by Region (2017-2022)
        2.5.2 Global Eye Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Eye Drug Sales by Manufacturers
        3.1.1 Global Top Eye Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Eye Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Eye Drug in 2021
    3.2 Global Eye Drug Revenue by Manufacturers
        3.2.1 Global Eye Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Eye Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Eye Drug Revenue in 2021
    3.3 Global Eye Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Eye Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Eye Drug Sales by Type
        4.1.1 Global Eye Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Eye Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Eye Drug Sales Market Share by Type (2017-2028)
    4.2 Global Eye Drug Revenue by Type
        4.2.1 Global Eye Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Eye Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Eye Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Eye Drug Price by Type
        4.3.1 Global Eye Drug Price by Type (2017-2022)
        4.3.2 Global Eye Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Eye Drug Sales by Application
        5.1.1 Global Eye Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Eye Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Eye Drug Sales Market Share by Application (2017-2028)
    5.2 Global Eye Drug Revenue by Application
        5.2.1 Global Eye Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Eye Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Eye Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Eye Drug Price by Application
        5.3.1 Global Eye Drug Price by Application (2017-2022)
        5.3.2 Global Eye Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Eye Drug Market Size by Type
        6.1.1 North America Eye Drug Sales by Type (2017-2028)
        6.1.2 North America Eye Drug Revenue by Type (2017-2028)
    6.2 North America Eye Drug Market Size by Application
        6.2.1 North America Eye Drug Sales by Application (2017-2028)
        6.2.2 North America Eye Drug Revenue by Application (2017-2028)
    6.3 North America Eye Drug Market Size by Country
        6.3.1 North America Eye Drug Sales by Country (2017-2028)
        6.3.2 North America Eye Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Eye Drug Market Size by Type
        7.1.1 Europe Eye Drug Sales by Type (2017-2028)
        7.1.2 Europe Eye Drug Revenue by Type (2017-2028)
    7.2 Europe Eye Drug Market Size by Application
        7.2.1 Europe Eye Drug Sales by Application (2017-2028)
        7.2.2 Europe Eye Drug Revenue by Application (2017-2028)
    7.3 Europe Eye Drug Market Size by Country
        7.3.1 Europe Eye Drug Sales by Country (2017-2028)
        7.3.2 Europe Eye Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Eye Drug Market Size by Type
        8.1.1 Asia Pacific Eye Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Eye Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Eye Drug Market Size by Application
        8.2.1 Asia Pacific Eye Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Eye Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Eye Drug Market Size by Region
        8.3.1 Asia Pacific Eye Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Eye Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Eye Drug Market Size by Type
        9.1.1 Latin America Eye Drug Sales by Type (2017-2028)
        9.1.2 Latin America Eye Drug Revenue by Type (2017-2028)
    9.2 Latin America Eye Drug Market Size by Application
        9.2.1 Latin America Eye Drug Sales by Application (2017-2028)
        9.2.2 Latin America Eye Drug Revenue by Application (2017-2028)
    9.3 Latin America Eye Drug Market Size by Country
        9.3.1 Latin America Eye Drug Sales by Country (2017-2028)
        9.3.2 Latin America Eye Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Eye Drug Market Size by Type
        10.1.1 Middle East and Africa Eye Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Eye Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Eye Drug Market Size by Application
        10.2.1 Middle East and Africa Eye Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Eye Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Eye Drug Market Size by Country
        10.3.1 Middle East and Africa Eye Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Eye Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Corporation Information
        11.2.2 Novartis Overview
        11.2.3 Novartis Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis Recent Developments
    11.3 bausch Lomb
        11.3.1 bausch Lomb Corporation Information
        11.3.2 bausch Lomb Overview
        11.3.3 bausch Lomb Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 bausch Lomb Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 bausch Lomb Recent Developments
    11.4 Laboratoire Riva
        11.4.1 Laboratoire Riva Corporation Information
        11.4.2 Laboratoire Riva Overview
        11.4.3 Laboratoire Riva Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Laboratoire Riva Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Laboratoire Riva Recent Developments
    11.5 Jamp Pharma
        11.5.1 Jamp Pharma Corporation Information
        11.5.2 Jamp Pharma Overview
        11.5.3 Jamp Pharma Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Jamp Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Jamp Pharma Recent Developments
    11.6 Fresenius
        11.6.1 Fresenius Corporation Information
        11.6.2 Fresenius Overview
        11.6.3 Fresenius Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Fresenius Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Fresenius Recent Developments
    11.7 Teva Pharmaceutical?
        11.7.1 Teva Pharmaceutical? Corporation Information
        11.7.2 Teva Pharmaceutical? Overview
        11.7.3 Teva Pharmaceutical? Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Teva Pharmaceutical? Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Teva Pharmaceutical? Recent Developments
    11.8 SANDOZ
        11.8.1 SANDOZ Corporation Information
        11.8.2 SANDOZ Overview
        11.8.3 SANDOZ Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 SANDOZ Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 SANDOZ Recent Developments
    11.9 Greenstone
        11.9.1 Greenstone Corporation Information
        11.9.2 Greenstone Overview
        11.9.3 Greenstone Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Greenstone Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Greenstone Recent Developments
    11.10 Mylan
        11.10.1 Mylan Corporation Information
        11.10.2 Mylan Overview
        11.10.3 Mylan Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Mylan Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Mylan Recent Developments
    11.11 GE Medical
        11.11.1 GE Medical Corporation Information
        11.11.2 GE Medical Overview
        11.11.3 GE Medical Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 GE Medical Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 GE Medical Recent Developments
    11.12 Mint Pharmaceuticals
        11.12.1 Mint Pharmaceuticals Corporation Information
        11.12.2 Mint Pharmaceuticals Overview
        11.12.3 Mint Pharmaceuticals Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Mint Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Mint Pharmaceuticals Recent Developments
    11.13 Laboratoires Thea
        11.13.1 Laboratoires Thea Corporation Information
        11.13.2 Laboratoires Thea Overview
        11.13.3 Laboratoires Thea Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Laboratoires Thea Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Laboratoires Thea Recent Developments
    11.14 Taj Pharmaceuticals
        11.14.1 Taj Pharmaceuticals Corporation Information
        11.14.2 Taj Pharmaceuticals Overview
        11.14.3 Taj Pharmaceuticals Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Taj Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Taj Pharmaceuticals Recent Developments
    11.15 Actavis
        11.15.1 Actavis Corporation Information
        11.15.2 Actavis Overview
        11.15.3 Actavis Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Actavis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Actavis Recent Developments
    11.16 APOTEX
        11.16.1 APOTEX Corporation Information
        11.16.2 APOTEX Overview
        11.16.3 APOTEX Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 APOTEX Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 APOTEX Recent Developments
    11.17 Sun Pharma
        11.17.1 Sun Pharma Corporation Information
        11.17.2 Sun Pharma Overview
        11.17.3 Sun Pharma Eye Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Sun Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Sun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Eye Drug Industry Chain Analysis
    12.2 Eye Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Eye Drug Production Mode & Process
    12.4 Eye Drug Sales and Marketing
        12.4.1 Eye Drug Sales Channels
        12.4.2 Eye Drug Distributors
    12.5 Eye Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Eye Drug Industry Trends
    13.2 Eye Drug Market Drivers
    13.3 Eye Drug Market Challenges
    13.4 Eye Drug Market Restraints
14 Key Findings in The Global Eye Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Eye Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Drops
    Table 3. Major Manufacturers of Tablet & Capsule
    Table 4. Global Eye Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Eye Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Eye Drug Sales by Region (2017-2022) & (MT)
    Table 7. Global Eye Drug Sales Market Share by Region (2017-2022)
    Table 8. Global Eye Drug Sales by Region (2023-2028) & (MT)
    Table 9. Global Eye Drug Sales Market Share by Region (2023-2028)
    Table 10. Global Eye Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Eye Drug Revenue Market Share by Region (2017-2022)
    Table 12. Global Eye Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Eye Drug Revenue Market Share by Region (2023-2028)
    Table 14. Global Eye Drug Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Eye Drug Sales Share by Manufacturers (2017-2022)
    Table 16. Global Eye Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Eye Drug Revenue Share by Manufacturers (2017-2022)
    Table 18. Eye Drug Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 19. Global Eye Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Eye Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Drug as of 2021)
    Table 21. Eye Drug Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Eye Drug Product Offered
    Table 23. Date of Manufacturers Enter into Eye Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Eye Drug Sales by Type (2017-2022) & (MT)
    Table 26. Global Eye Drug Sales by Type (2023-2028) & (MT)
    Table 27. Global Eye Drug Sales Share by Type (2017-2022)
    Table 28. Global Eye Drug Sales Share by Type (2023-2028)
    Table 29. Global Eye Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Eye Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Eye Drug Revenue Share by Type (2017-2022)
    Table 32. Global Eye Drug Revenue Share by Type (2023-2028)
    Table 33. Eye Drug Price by Type (2017-2022) & (USD/Kg)
    Table 34. Global Eye Drug Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 35. Global Eye Drug Sales by Application (2017-2022) & (MT)
    Table 36. Global Eye Drug Sales by Application (2023-2028) & (MT)
    Table 37. Global Eye Drug Sales Share by Application (2017-2022)
    Table 38. Global Eye Drug Sales Share by Application (2023-2028)
    Table 39. Global Eye Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Eye Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Eye Drug Revenue Share by Application (2017-2022)
    Table 42. Global Eye Drug Revenue Share by Application (2023-2028)
    Table 43. Eye Drug Price by Application (2017-2022) & (USD/Kg)
    Table 44. Global Eye Drug Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 45. North America Eye Drug Sales by Type (2017-2022) & (MT)
    Table 46. North America Eye Drug Sales by Type (2023-2028) & (MT)
    Table 47. North America Eye Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Eye Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Eye Drug Sales by Application (2017-2022) & (MT)
    Table 50. North America Eye Drug Sales by Application (2023-2028) & (MT)
    Table 51. North America Eye Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Eye Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Eye Drug Sales by Country (2017-2022) & (MT)
    Table 54. North America Eye Drug Sales by Country (2023-2028) & (MT)
    Table 55. North America Eye Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Eye Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Eye Drug Sales by Type (2017-2022) & (MT)
    Table 58. Europe Eye Drug Sales by Type (2023-2028) & (MT)
    Table 59. Europe Eye Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Eye Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Eye Drug Sales by Application (2017-2022) & (MT)
    Table 62. Europe Eye Drug Sales by Application (2023-2028) & (MT)
    Table 63. Europe Eye Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Eye Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Eye Drug Sales by Country (2017-2022) & (MT)
    Table 66. Europe Eye Drug Sales by Country (2023-2028) & (MT)
    Table 67. Europe Eye Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Eye Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Eye Drug Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Eye Drug Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Eye Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Eye Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Eye Drug Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Eye Drug Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Eye Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Eye Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Eye Drug Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Eye Drug Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Eye Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Eye Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Eye Drug Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Eye Drug Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Eye Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Eye Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Eye Drug Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Eye Drug Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Eye Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Eye Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Eye Drug Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Eye Drug Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Eye Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Eye Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Eye Drug Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Eye Drug Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Eye Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Eye Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Eye Drug Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Eye Drug Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Eye Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Eye Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Eye Drug Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Eye Drug Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Eye Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Eye Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Pfizer Corporation Information
    Table 106. Pfizer Description and Major Businesses
    Table 107. Pfizer Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 108. Pfizer Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Pfizer Recent Developments
    Table 110. Novartis Corporation Information
    Table 111. Novartis Description and Major Businesses
    Table 112. Novartis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Novartis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Novartis Recent Developments
    Table 115. bausch Lomb Corporation Information
    Table 116. bausch Lomb Description and Major Businesses
    Table 117. bausch Lomb Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. bausch Lomb Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. bausch Lomb Recent Developments
    Table 120. Laboratoire Riva Corporation Information
    Table 121. Laboratoire Riva Description and Major Businesses
    Table 122. Laboratoire Riva Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. Laboratoire Riva Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Laboratoire Riva Recent Developments
    Table 125. Jamp Pharma Corporation Information
    Table 126. Jamp Pharma Description and Major Businesses
    Table 127. Jamp Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 128. Jamp Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Jamp Pharma Recent Developments
    Table 130. Fresenius Corporation Information
    Table 131. Fresenius Description and Major Businesses
    Table 132. Fresenius Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 133. Fresenius Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Fresenius Recent Developments
    Table 135. Teva Pharmaceutical? Corporation Information
    Table 136. Teva Pharmaceutical? Description and Major Businesses
    Table 137. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 138. Teva Pharmaceutical? Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Teva Pharmaceutical? Recent Developments
    Table 140. SANDOZ Corporation Information
    Table 141. SANDOZ Description and Major Businesses
    Table 142. SANDOZ Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 143. SANDOZ Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. SANDOZ Recent Developments
    Table 145. Greenstone Corporation Information
    Table 146. Greenstone Description and Major Businesses
    Table 147. Greenstone Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 148. Greenstone Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Greenstone Recent Developments
    Table 150. Mylan Corporation Information
    Table 151. Mylan Description and Major Businesses
    Table 152. Mylan Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 153. Mylan Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Mylan Recent Developments
    Table 155. GE Medical Corporation Information
    Table 156. GE Medical Description and Major Businesses
    Table 157. GE Medical Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 158. GE Medical Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. GE Medical Recent Developments
    Table 160. Mint Pharmaceuticals Corporation Information
    Table 161. Mint Pharmaceuticals Description and Major Businesses
    Table 162. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 163. Mint Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Mint Pharmaceuticals Recent Developments
    Table 165. Laboratoires Thea Corporation Information
    Table 166. Laboratoires Thea Description and Major Businesses
    Table 167. Laboratoires Thea Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 168. Laboratoires Thea Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Laboratoires Thea Recent Developments
    Table 170. Taj Pharmaceuticals Corporation Information
    Table 171. Taj Pharmaceuticals Description and Major Businesses
    Table 172. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 173. Taj Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Taj Pharmaceuticals Recent Developments
    Table 175. Actavis Corporation Information
    Table 176. Actavis Description and Major Businesses
    Table 177. Actavis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 178. Actavis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Actavis Recent Developments
    Table 180. APOTEX Corporation Information
    Table 181. APOTEX Description and Major Businesses
    Table 182. APOTEX Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 183. APOTEX Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. APOTEX Recent Developments
    Table 185. Sun Pharma Corporation Information
    Table 186. Sun Pharma Description and Major Businesses
    Table 187. Sun Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 188. Sun Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Sun Pharma Recent Developments
    Table 190. Key Raw Materials Lists
    Table 191. Raw Materials Key Suppliers Lists
    Table 192. Eye Drug Distributors List
    Table 193. Eye Drug Customers List
    Table 194. Eye Drug Market Trends
    Table 195. Eye Drug Market Drivers
    Table 196. Eye Drug Market Challenges
    Table 197. Eye Drug Market Restraints
    Table 198. Research Programs/Design for This Report
    Table 199. Key Data Information from Secondary Sources
    Table 200. Key Data Information from Primary Sources
List of Figures
    Figure 1. Eye Drug Product Picture
    Figure 3. Global Eye Drug Market Share by Type in 2021 & 2028
    Figure 3. Drops Product Picture
    Figure 4. Tablet & Capsule Product Picture
    Figure 5. Global Eye Drug Market Share by Application in 2021 & 2028
    Figure 6. Glaucoma
    Figure 7. Retinal Disease
    Figure 8. Bacterial?Infection
    Figure 9. Other
    Figure 10. Eye Drug Report Years Considered
    Figure 11. Global Eye Drug Sales 2017-2028 (MT)
    Figure 12. Global Eye Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Eye Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Eye Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Eye Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Eye Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Eye Drug Sales YoY (2017-2028) & (MT)
    Figure 18. North America Eye Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Eye Drug Sales YoY (2017-2028) & (MT)
    Figure 20. Europe Eye Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Eye Drug Sales YoY (2017-2028) & (MT)
    Figure 22. Asia-Pacific Eye Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Eye Drug Sales YoY (2017-2028) & (MT)
    Figure 24. Latin America Eye Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Eye Drug Sales YoY (2017-2028) & (MT)
    Figure 26. Middle East & Africa Eye Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Eye Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Eye Drug in the World: Market Share by Eye Drug Revenue in 2021
    Figure 29. Global Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Eye Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Eye Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Eye Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Eye Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Eye Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Eye Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Eye Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Eye Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Eye Drug Sales Share by Country (2017-2028)
    Figure 39. North America Eye Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Eye Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Eye Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Eye Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Eye Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Eye Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Eye Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Eye Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Eye Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Eye Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Eye Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Eye Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Eye Drug Revenue Share by Region (2017-2028)
    Figure 59. China Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Eye Drug Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Eye Drug Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Eye Drug Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Eye Drug Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Eye Drug Sales Share by Country (2017-2028)
    Figure 74. Latin America Eye Drug Revenue Share by Country (2017-2028)
    Figure 75. Mexico Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Eye Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Eye Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Eye Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Eye Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Eye Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Eye Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Eye Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Eye Drug Value Chain
    Figure 88. Eye Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma
Frequently Asked Questions
Eye Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Eye Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Eye Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Braided Hoses

Braided Hoses market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Braided Piping

Braided Piping market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More